Medical Conference Schedule Sept. 2013 through March 2014

A Health Sciences Stock Positioned To Break Out of a Giant Base Pattern
Source: Clive Maund (05/27/2025)

Technical Analyst Clive Maund explains why he thinks PreveCeutical Medical Inc. (PREV:CSE; PRVCF:OTCMKTS) is ready to break out and is rated a Strong Buy.

read more >

Co. Poised to Begin Major New Bull Market
Source: Clive Maund (05/23/2025)

Technical Analyst Clive Maund explains why he thinks Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is an Immediate Strong Buy.

read more >

Co. Prepares to Roll Out Wound Irrigating Solution
Source: Richard Ryan (05/21/2025)

BioLargo Inc.'s (BLGO:OTCQX) subsidiary has all the necessary partners in place and working on integrating the various systems, such as purchasing, accounting, forecasting, logistics and quality assurance, noted an Oak Ridge Financial report.

read more >

Centrally Positioned AI Co. Platform Designed To Transform Healthcare
Source: Clive Maund (05/21/2025)

Technical Analyst Clive Maund explains why he thinks now is an excellent time to buy or add to positions in Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA).

read more >

Interim Data From TID Trial Are Positive
Source: Streetwise Reports (05/15/2025)

Sernova Biotherapeutics Inc.'s (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) regenerative treatment delivered via its Cell Pouch Bio-hybrid Organ is proving to result in insulin independence, among other outcomes. Read what one analyst says are the implications of this clear medical benefit.

read more >